Dementia with Lewy bodies

Article section 15 of 15.  Previous  

By Ann Marie Hake MD

Ann Marie Hake MD, author. Dr. Hake of the Indiana University School of Medicine received honorariums from Accera, Eisai, Novarits, and Pfizer for speaking engagements and salary as an employee for Eli Lilly and Co.

Martin Farlow MD, editor. Dr. Farlow of Indiana University School of Medicine received grant or research support from Eli Lilly, Novartis, Sanofi Aventis, Roche, Genentech, Eisai, Biogen, Accera and Navidea; speakers bureau fees from Eisai, Pfizer, Forest and Novartis; consulting or advisory board fees from Accera, Alltech, Avanir, Eisai, Med Res, Inc., Grifols, Helicon, INC Research, Medavante, Medivation, Inc., Merck, Novartis, Pfizer, Prana Biotech, QR Pharma, Roche, Sanofi Aventis, Schering-Plough, Toyama Pharm, Lilly, Shire Pharmaceuticals, UCB Pharma; and patent licensing fees from Elan.

In This Article

Historical note and nomenclature
Clinical manifestations
Clinical vignette
Pathogenesis and pathophysiology
Differential diagnosis
Diagnostic workup
Prognosis and complications
References cited